Clinical features of patients undergoing hemodialysis with COVID-19

Ming Tian1, Hua Li1, Ting Yan2

  • 1Department of Nephrology, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.

Seminars in Dialysis
|October 29, 2020
PubMed

Insights

Hemodialysis patients with COVID-19 often show lymphocytopenia and lung opacities, but these signs aren't unique. Early treatment is key to reducing mortality and infection risk in this vulnerable group.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pulmonology

Background:

  • Patients undergoing hemodialysis face increased susceptibility to infections, including coronavirus disease 2019 (COVID-19).
  • Understanding the specific clinical and epidemiological profile of COVID-19 in hemodialysis patients is crucial for effective management.

Purpose of the Study:

  • To describe the epidemiological and clinical characteristics of hemodialysis patients with COVID-19.
  • To identify mortality-related risk factors in this patient population.

Main Methods:

  • A retrospective study comparing 49 hemodialysis patients with COVID-19 (Group 1) to 74 uninfected hemodialysis patients (Group 2).
  • Analysis of demographic data, comorbidities, clinical symptoms, laboratory results (blood routine, lymphocyte subsets), and chest CT findings.

Main Results:

  • The median age of infected patients was 62 years, with 59.3% males and a median dialysis vintage of 26 months.
  • Common symptoms included fever (32.7%) and dry cough (46.9%); 18.4% were asymptomatic. Lymphocytopenia and reduced lymphocyte subsets were observed.
  • Chest CT scans revealed ground-glass opacity (45.8%) and patchy shadowing (35.4%), findings not exclusive to COVID-19 in this cohort.

Conclusions:

  • Lymphocytopenia and specific CT findings are common in hemodialysis patients with COVID-19 but lack specificity.
  • Early intervention and management of nosocomial infections are vital for reducing mortality and SARS-CoV-2 infection risk in hemodialysis patients.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
364
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
941
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.3K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
389
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
493
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
792